title: Results from an open-label extension study of etanercept in ankylosing spondylitis.
authors.forename: John
authors.initials: J
authors.lastname: Davis
authors.forename: Allison
authors.initials: A
authors.lastname: Webb
authors.forename: Steven
authors.initials: S
authors.lastname: Lund
authors.forename: Kenneth
authors.initials: K
authors.lastname: Sack
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000009:adverse effects; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept